FINWIRES · TerminalLIVE
FINWIRES

Citigroup Upgrades Haemonetics to Buy From Neutral, Adjusts Price Target to $123 From $92

By

Haemonetics (HAE) has an average rating of overweight and mean price target of $108.40, according to analysts polled by FactSet.

What else is happening in Research?